tiprankstipranks
Geron announces $375M in synthetic royalty, debt financings with Royalty Pharma
PremiumThe FlyGeron announces $375M in synthetic royalty, debt financings with Royalty Pharma
2M ago
Royalty Pharma to acquire royalty interest in Geron’s RYTELO for $125M
Premium
The Fly
Royalty Pharma to acquire royalty interest in Geron’s RYTELO for $125M
2M ago
Geron reports Q3 EPS (4c), consensus (8c)
Premium
The Fly
Geron reports Q3 EPS (4c), consensus (8c)
2M ago
Disney initiated, Cisco upgraded: Wall Street’s top analyst calls
PremiumThe FlyDisney initiated, Cisco upgraded: Wall Street’s top analyst calls
2M ago
Geron initiated with an Outperform at Scotiabank
Premium
The Fly
Geron initiated with an Outperform at Scotiabank
2M ago
Longboard Pharmaceuticals downgraded to Neutral from Buy at B. Riley
Premium
The Fly
Longboard Pharmaceuticals downgraded to Neutral from Buy at B. Riley
2M ago
Geron price target raised to $5.50 from $5 at B. Riley
PremiumThe FlyGeron price target raised to $5.50 from $5 at B. Riley
5M ago
Geron reports Q2 EPS (10c), consensus (10c)
Premium
The Fly
Geron reports Q2 EPS (10c), consensus (10c)
5M ago
Is GERN a Buy, Before Earnings?
Premium
Pre-Earnings
Is GERN a Buy, Before Earnings?
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100